Osteosarcoma is the most common primary bone tumor, and its first line of treatment presents a high failure rate. The 5-year survival for children and teenagers with …
ST Menéndez, B Gallego, D Murillo… - Journal of Clinical …, 2021 - mdpi.com
Bone sarcomas are commonly characterized by a high degree of intra-tumor heterogeneity, which in part is due to the presence of subpopulations of tumor cells presenting stem cell …
J Zeng, Y Peng, D Wang, K Ayesha… - Frontiers in Cell and …, 2023 - frontiersin.org
Osteosarcoma is a primary bone tumor with a high mortality rate. The event-free survival rate has not improved significantly in the past 30 years, which brings a heavy burden to patients …
P Yao, Y Lu, Z Cai, T Yu, Y Kang, Y Zhang… - Cancer …, 2022 - journals.sagepub.com
Currently, although the improvement of surgical techniques and the development of chemotherapy drugs have brought a certain degree of development to the treatment of …
Y Wang, N Wang, Y Yang, Y Chen, Z Zhang - Journal of …, 2022 - Springer
Gene transfection was supposed to be the most promising technology to overcome the vast majority of diseases and it has been popularly reported in clinical applications of gene …
It only took 8 months for the pneumonia caused by a previously unknown coronavirus to turn into a global pandemic of unprecedentedly far-reaching implications. Failure of the already …
MA Kang, PP Rao, H Matsui, SS Mahajan - International Journal of …, 2022 - mdpi.com
Although osteosarcoma is the most common primary malignant bone tumor, chemotherapeutic drugs and treatment have failed to increase the five-year survival rate …
F Pu, F Chen, Z Zhang, J Liu, Z Shao - OncoTargets and therapy, 2020 - Taylor & Francis
Osteosarcoma is a highly invasive kind of malignant bone tumor. Exosomes are a type of extracellular vesicles that play an important role in intercellular communication in the …